Operating Lease, Right-of-Use Asset in USD of REPLIGEN CORP from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REPLIGEN CORP quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • REPLIGEN CORP Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $124M, a 2.44% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REPLIGEN CORP Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $124M -$3.11M -2.44% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $128M -$3.77M -2.87% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $130M -$4.93M -3.67% 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $135M +$19.9M +17.2% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $127M +$9.18M +7.78% 30 Sep 2024 10-Q 18 Nov 2024
Q2 2024 $131M +$9.41M +7.71% 30 Jun 2024 10-Q/A 18 Nov 2024
Q1 2024 $135M +$12.8M +10.5% 31 Mar 2024 10-Q/A 18 Nov 2024
Q4 2023 $116M -$9.51M -7.61% 31 Dec 2023 10-K 14 Mar 2025
Q3 2023 $118M -$3.44M -2.83% 30 Sep 2023 10-Q/A 18 Nov 2024
Q2 2023 $122M +$705K +0.58% 30 Jun 2023 10-Q/A 18 Nov 2024
Q1 2023 $122M +$22.1M +22.1% 31 Mar 2023 10-Q/A 18 Nov 2024
Q4 2022 $125M +$23.5M +23.1% 31 Dec 2022 10-K/A 18 Nov 2024
Q3 2022 $122M +$66.5M +121% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $121M +$71.2M +142% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $99.8M +$72.7M +269% 31 Mar 2022 10-Q 27 Apr 2022
Q4 2021 $102M +$76.4M +303% 31 Dec 2021 10-K 22 Feb 2023
Q3 2021 $55M +$30.8M +127% 30 Sep 2021 10-Q 28 Oct 2021
Q2 2021 $50.2M +$26.3M +111% 30 Jun 2021 10-Q 27 Jul 2021
Q1 2021 $27M +$2.35M +9.5% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 $25.2M -$531K -2.07% 31 Dec 2020 10-K 17 Feb 2022
Q3 2020 $24.2M -$644K -2.59% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $23.8M +$4.33M +22.2% 30 Jun 2020 10-Q 30 Jul 2020
Q1 2020 $24.7M +$5.19M +26.6% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $25.7M 31 Dec 2019 10-K 24 Feb 2021
Q3 2019 $24.8M 30 Sep 2019 10-Q 31 Oct 2019
Q2 2019 $19.5M 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $19.5M 31 Mar 2019 10-Q 01 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.